心房細動(Atrial Fibrillation)の治療薬パイプライン動向(2015年上半期版)...市場調査レポートについてご紹介

【英文タイトル】Atrial Fibrillation - Pipeline Review, H1 2015

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 6
List of Figures 7
Introduction 8
Global Markets Direct Report Coverage 8
Atrial Fibrillation Overview 9
Therapeutics Development 10
Pipeline Products for Atrial Fibrillation – Overview 10
Pipeline Products for Atrial Fibrillation – Comparative Analysis 11
Atrial Fibrillation – Therapeutics under Development by Companies 12
Atrial Fibrillation – Pipeline Products Glance 14
Late Stage Products 14
Clinical Stage Products 15
Early Stage Products 16
Atrial Fibrillation – Products under Development by Companies 17
Atrial Fibrillation – Companies Involved in Therapeutics Development 19
ARCA biopharma, Inc. 19
Armetheon, Inc. 20
AstraZeneca PLC 21
Bristol-Myers Squibb Company 22
Cardiome Pharma Corp 23
Daiichi Sankyo Company, Limited 24
Gilead Sciences, Inc. 25
Isis Pharmaceuticals, Inc. 26
Laboratoires Pierre Fabre SA 27
Nissan Chemical Industries, Ltd. 28
Nyken BV 29
Otsuka Holdings Co., Ltd. 30
Regado Biosciences, Inc. 31
Serodus ASA 32
Xention Limited 33
Atrial Fibrillation – Therapeutics Assessment 34
Assessment by Monotherapy Products 34
Assessment by Combination Products 35
Assessment by Target 36
Assessment by Mechanism of Action 38
Assessment by Route of Administration 40
Assessment by Molecule Type 42
Drug Profiles 44
(ranolazine + dronedarone) – Drug Profile 44
Product Description 44
Mechanism of Action 44
R&D Progress 44
Aptamers for Cardiovascular Diseases – Drug Profile 46
Product Description 46
Mechanism of Action 46
R&D Progress 46
BMS-919373 – Drug Profile 47
Product Description 47
Mechanism of Action 47
R&D Progress 47
bucindolol hydrochloride – Drug Profile 48
Product Description 48
Mechanism of Action 48
R&D Progress 48
budiodarone – Drug Profile 50
Product Description 50
Mechanism of Action 50
R&D Progress 50
Drug For Atrial Fibrillation – Drug Profile 52
Product Description 52
Mechanism of Action 52
R&D Progress 52
edoxaban tosylate – Drug Profile 53
Product Description 53
Mechanism of Action 53
R&D Progress 53
F-373280 – Drug Profile 55
Product Description 55
Mechanism of Action 55
R&D Progress 55
GsMTx-4 – Drug Profile 56
Product Description 56
Mechanism of Action 56
R&D Progress 56
ISIS-CRPRx – Drug Profile 58
Product Description 58
Mechanism of Action 58
R&D Progress 58
NIP-151 – Drug Profile 59
Product Description 59
Mechanism of Action 59
R&D Progress 59
NYK-1112 – Drug Profile 61
Product Description 61
Mechanism of Action 61
R&D Progress 61
OMT-33 – Drug Profile 62
Product Description 62
Mechanism of Action 62
R&D Progress 62
OPC-108459 – Drug Profile 63
Product Description 63
Mechanism of Action 63
R&D Progress 63
ranolazine ER – Drug Profile 64
Product Description 64
Mechanism of Action 64
R&D Progress 64
SER-102 – Drug Profile 66
Product Description 66
Mechanism of Action 66
R&D Progress 66
Small Molecule to Block IKACh for Atrial Fibrillation – Drug Profile 67
Product Description 67
Mechanism of Action 67
R&D Progress 67
Small Molecule to Block Kv1.5 for Atrial Fibrillation – Drug Profile 68
Product Description 68
Mechanism of Action 68
R&D Progress 68
Small Molecules to Activate Heat Shock Protein 70 (Hsp70) for Post-Operative Atrial Fibrillation – Drug Profile 69
Product Description 69
Mechanism of Action 69
R&D Progress 69
Small Molecules to Block Voltage Gated Sodium Channel for Atrial Fibrillation – Drug Profile 70
Product Description 70
Mechanism of Action 70
R&D Progress 70
vanoxerine – Drug Profile 72
Product Description 72
Mechanism of Action 72
R&D Progress 72
vernakalant hydrochloride – Drug Profile 73
Product Description 73
Mechanism of Action 73
R&D Progress 73
XEN-D0101 – Drug Profile 75
Product Description 75
Mechanism of Action 75
R&D Progress 75
XEN-D0103 – Drug Profile 76
Product Description 76
Mechanism of Action 76
R&D Progress 76
XEN-R0702 – Drug Profile 77
Product Description 77
Mechanism of Action 77
R&D Progress 77
Atrial Fibrillation – Recent Pipeline Updates 78
Atrial Fibrillation – Dormant Projects 90
Atrial Fibrillation – Discontinued Products 94
Atrial Fibrillation – Product Development Milestones 95
Featured News & Press Releases 95
Dec 08, 2014: Daiichi Sankyo Launches New Formulation of LIXIANA 60 mg Tablets (edoxaban) in Japan 95
Nov 07, 2014: Cardiome Announces Positive Results from the BRINAVESS Asia-Pacific Phase 3 Clinical Trial 95
Nov 07, 2014: Cardiome Submits BRINAVESS Reimbursement Dossier to Italian Authorities to Support Market Access 96
Oct 31, 2014: U.S. FDA Cardiovascular and Renal Drugs Advisory Committee Makes Recommendation on Daiichi Sankyo’s Once-Daily SAVAYSA™ (edoxaban) for the Reduction in Risk of Stroke and Systemic Embolic Events in Patients with Non-Valvular Atrial Fibrillation 96
Oct 28, 2014: U.S. FDA Cardiovascular and Renal Drugs Advisory Committee Makes Recommendation on Daiichi Sankyo’s Once-Daily SAVAYSA for the Reduction in Risk of Stroke and Systemic Embolic Events in Patients with Non-Valvular Atrial Fibrillation 97
Sep 26, 2014: Daiichi Sankyo Receives Approval for Additional Indications of LIXIANA (edoxaban) in Japan 98
Sep 02, 2014: Subgroup Analysis of ENGAGE AF-TIMI 48 Explores the Relationship Between Edoxaban Dose, Concentration, Anti-Factor Xa Activity and Outcomes 98
Sep 01, 2014: Xention commences first phase 2 study of XEN-D0103 in atrial fibrillation 100
Aug 25, 2014: Cardiome Enters Commercialization Agreement With Eurolab Especialidades Medicinales For BRINAVESS In Argentina 101
Aug 06, 2014: Cardiome Submits Brinavess Dossier To French Authorities To Support Market Access 101
Appendix 102
Methodology 102
Coverage 102
Secondary Research 102
Primary Research 102
Expert Panel Validation 102
Contact Us 103
Disclaimer 103


【レポート販売概要】

■ タイトル:心房細動(Atrial Fibrillation)の治療薬パイプライン動向(2015年上半期版)
■ 英文:Atrial Fibrillation - Pipeline Review, H1 2015
■ 発行日:2015年1月22日
■ 調査会社:Global Markets Direct
■ 商品コード:GMDHC6040IDB
■ 調査対象地域:グローバル
  • Sodium percarbonateの世界市場
    Sodium percarbonate (CAS 15630-89-4) Market Research Report 2013 presents comprehensive data on Sodium percarbonate markets globally and regionally (Europe, Asia, North America etc.) The Sodium percarbonate (CAS 15630-89-4) Market Research Report 2013 includes Sodium percarbonate description, covers its application areas and related patterns. It overviews Sodium percarbonate market, names Sodium p …
  • ゴルフウェアの世界市場:メンズゴルフウェア、レディースゴルフウェア、キッズゴルフウェア
    About golf apparel Golf is a popular sport and is highly popular among business individuals and amateur players. The game as apart from being an exercise also facilitates socializing. The game has relatively little physical requirement in comparison to other form of exercise and sports. Golf has not featured in the Olympics since 1904; however, with rapid expansion and globalization of the sport, …
  • 不可視視矯正装置の世界市場:クリア・アライナ、セラミック・ブレース、リンガル・ブレース
    About Orthodontics Orthodontics is a vital component of restorative or cosmetic dentistry. It deals with the treatment of malocclusions (improper alignment and bites) caused due to tooth irregularity, inappropriate jaw alignment, and gaps in teeth. Orthodontics can be classified into the following: clear aligners, ceramic braces, and lingual braces. Technavio’s analysts forecast the global invisib …
  • 世界の創傷被覆市場動向(2012-2016)
    TechNavio's analysts forecast the Global Wound Dressing market to grow at a CAGR of 5.6 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in the aging population. The Global Wound Dressing market has also been witnessing the trend of increasing demand for combination dressings. However, the high cost of advanced dressing products could pos …
  • 熱可塑性プラスチック管の世界市場:プラスチック種類(PE、PVDF、PVC、PP、PA)、用途、地域別分析
    The report provides a detailed analysis of thermoplastic pipes used in varied applications such as oil & gas, municipal, mining & dredging, and chemical. The market has also been categorized on the basis of region into Asia-Pacific, North America, Europe, the Middle East & Africa, and Latin America. The market has been further segmented based on the type of polymer used for manufacturing these pip …
  • Magellan Petroleum Corporation:石油・ガスの開発・生産動向及びコスト分析– 2012
    Magellan Petroleum Corporation Oil & Gas Exploration and Production Operations and Cost Analysis – 2012 Summary Magellan Petroleum Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an es …
  • 世界のパワーアシスト車椅子市場(2014-2018)
    TechNavio's analysts forecast the Global Powered Wheelchairs market to grow at a CAGR of 21.5 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing elderly population. The Global Powered Wheelchairs market has also been witnessing the introduction of lightweight smart chairs. However, the presence of substitutes could pose a challenge to the …
  • 世界のリターナブル輸送パッケージング(包装)市場動向(2014~2018)
    TechNavio's analysts forecast the Global Returnable Transport Packaging market to grow at a CAGR of 6.25 percent over the period 2013-2018. One of the key factors contributing to this market growth is the cost savings to consumers. The Global Returnable Transport Packaging market has also been witnessing the increasing use of returnable transport packaging for creating brand awareness. However, th …
  • 韓国の病院用品市場(~2021)
    South Korea Hospital Supplies Market Outlook to 2021 - Disposable Hospital Supplies, Mobility Aids and Transportation Equipment, Operating Room Equipment, Patient Examination Devices, Sterilization Equipment and Syringes and Needles Summary GlobalData’s new report, "South Korea Hospital Supplies Market Outlook to 2021 - Disposable Hospital Supplies, Mobility Aids and Transportation Equipment, Oper …
  • 世界の癌診断市場:がん遺伝子、マーカー、リンホカイン、GF、CSF、ホルモン、免疫組織化学的染色検査
    Complete report $34,500.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget. “2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohisto …
  • 高スループットプロセス開発の世界市場予測(~2021):モノクローナル抗体、組換えインスリン
    The global high throughput process development market is expected to reach USD 19.78 Billion in 2021 from USD 9.91 Billion in 2016, at a CAGR of 14.8% from 2016 to 2021.Growth in the market is mainly driven by the increasing R&D spending, technological advancements in process development, growth in the biopharmaceutical industry, and growing pressure to lower the cost of manufacturing. However, fa …
  • ペネトレーションテスト(侵入テスト)の世界市場予測(~2021)
    The penetration testing market size is expected to grow from USD 594.7 Million in 2016 to USD 1,724.3 Million by 2021, at a Compound Annual Growth Rate (CAGR) of 23.7% during the forecast period. The major growth drivers of the market include the increased sophistication level in attacking techniques, and the need to meet compliance requirements. The penetration testing market is segmented by test …
  • 世界の政府部門における生体認証システム市場
    Summary The Global Government Biometric Systems Market 2015-2025 report, published by Strategic Defence Intelligence, provides readers with a detailed analysis of both historic and forecast global industry values, factors influencing demand, the challenges faced by industry participants, analysis of industry leading companies, and key news. Key Findings - The global biometric systems market is est …
  • ヨーロッパのビタミンD検査市場
    In Europe, approximately 70% of the total population suffers from vitamin D deficiency, of which barely 5-6% has undergone vitamin D testing. This indicates that the vitamin D testing market in Europe is unpenetrated and has a high potential since the market has a large patient pool. Major vendors in Europe understand the potential market scenario and are constantly investing in R&D and innovating …
  • 人工心肺装置の世界市場2016-2020
    About the Heart-Lung Machines Market According to WHO, around 17.5 million people died due to cardiovascular diseases (CVDs) worldwide in 2012. As per the studies conducted by the American Heart Association (AHA) in 2014, deaths due to CVDs are likely to reach 24 million by 2030. CVDs include disorders associated with heart and blood vessels. Coronary heart disease is a condition in which sufficie …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。